Dr. Dubberke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
660 S Euclid Ave
# 8015
Saint Louis, MO 63110Phone+1 314-362-9098Fax+1 855-202-2372- Is this information wrong?
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Infectious Disease, 2002 - 2004
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1999 - 2002
- University of Illinois College of MedicineClass of 1999
Certifications & Licensure
- MO State Medical License 2000 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Autologous Fecal Therapy Start of enrollment: 2014 Mar 01
- Fecal Microbiota Transplantation (FMT) for MDRO UTI Start of enrollment: 2018 Feb 08
- TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment Start of enrollment: 2017 Dec 29
- Join now to see all
Publications & Presentations
PubMed
- Genomic surveillance oftransmission and virulence in a healthcare setting.Erin P Newcomer, Skye R S Fishbein, Kailun Zhang, Tiffany Hink, Kimberly A Reske, Candice Cass, Zainab H Iqbal, Emily L Struttmann, Carey-Ann D Burnham, Erik R Dubberk...> ;Mbio. 2024 Mar 13
- A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes ...Okhuysen, P., Ramesh, M., Louie, T., Kiknadze, N., Torre-Cisneros, J., de Oliveira, C., Van Steenkiste, C., Stychneuskaya, A., Garey, K., Garcia-Diaz, J., Li, J., Dupe...> ;Clinical Infectious Diseases. 2024 Feb 2
- Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides diff...Allegretti, J., Guo, A., Harvey, A., Yang, M., Garcia-Horton, V., Fillbrunn, M., Tillotson, G., Bancke, L., LaPlante, K., Garey, K., Khanna, S., Feuerstadt, P., Dubber...> ;Infectious Diseases and Therapy. 2024 Jan 1
- Join now to see all
Press Mentions
- Theriva Biologics Announces Presentation of Data from Cohort 1 of the Phase 1b/2a Clinical Trial of SYN-004 (Ribaxamase) in Allogeneic Hematopoietic Cell Transplant RecipientsApril 13th, 2023
- Synthetic Biologics Reports Second Quarter 2019 Operational Highlights and Financial ResultsNovember 4th, 2019
- Gut Makeup Could Make Diarrhea Less LikelyAugust 16th, 2019
- Join now to see all
Grant Support
- C. Difficile Disease In Stem Cell Transplant RecipientsNational Institute Of Allergy And Infectious Diseases2009–2011
- Validation And Modeling Of A C. Difficile Infection Risk Prediction IndexNational Institute Of Nursing Research2009–2010
Hospital Affiliations
- Barnes-Jewish HospitalSaint Louis, Missouri
- Siteman Cancer CenterSaint Louis, Missouri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: